ArticleFrontiers in oncology2025

Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion.

Hongtao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.